ArticleJournal of orthopaedic surgery and research2025
The application of ultrasound-guided percutaneous transforaminal endoscopy in treating carpal tunnel syndrome.
Article in Journal of orthopaedic surgery and research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
STUDY
designThis is a prospective cohort study.
objectiveThe purpose of this study is to evaluate the clinical outcomes of ultrasound-guided percutaneous transforaminal endoscopy in the treatment of CTS. Currently, the primary surgical approaches for carpal tunnel syndrome (CTS) are open release and endoscopic surgery, each with distinct advantages and limitations. The ultrasound-guided percutaneous transforaminal endoscopy is a modified endoscopic minimally invasive treatment for CTS. MATERIALS AND
methodsA total of 36 CTS patients (39 wrists) were collected From January 2021 to June 2024 in the study. Ultrasound was employed to locate the transverse carpal ligament and median nerve, followed by carpal tunnel release using the transforaminal endoscopic system. Hand symptoms and function were assessed at 2 weeks, 1 month, 3 months and 6 months postoperatively using the Boston Carpal Tunnel Questionnaire-Symptom Severity Score (BCTQ-S) and the Boston Carpal Tunnel Questionnaire-Function Status Scale (BCTQ-F). Preoperative and 6-month postoperative median nerve cross-sectional area (CSA) and flattening ratio of the median nerve were measured with high-frequency ultrasound. And the occurrence of scar pain and postoperative complications were observed.
resultsAt all follow-up points, both BCTQ-S and BCTQ-F scores were significantly lower than their preoperative values (P < 0.05). At the 6-month follow-up, the median nerve CSA and the flattening ratio demonstrated marked improvement (P < 0.05). No cases of nerve or vascular injury or incision infections were reported, and only 2 out of the 39 treated wrists developed painful scar.
conclusionThe combination of ultrasound guidance and transforaminal endoscopic release of the transverse carpal ligament has been proven to be an effective and safe treatment for CTS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.